Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency

The receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mediates the viral–host interaction and is a target for most neutralizing antibodies. Nevertheless, SARS-CoV-2 RBD mutations pose a threat due to their role in host cell entry via the human angiotensin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaofi, Ahmed L., Shahid, Mudassar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466379/
https://www.ncbi.nlm.nih.gov/pubmed/34572486
http://dx.doi.org/10.3390/biom11091273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466379/
https://www.ncbi.nlm.nih.gov/pubmed/34572486
http://dx.doi.org/10.3390/biom11091273

Ejemplares similares